Not applicableNot Yet RecruitingNCT06762925
What this trial is testing
Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment
Who this might be right for
Bladder CancerProstate CancerKidney Cancer
Xijing Hospital 450